Welcome to Lab Test Consult

You can log in and post your comments

Share your knowledge and experience!

Member Login
Lost your password?

Targeted Radiation for Breast Cancer May Be Overused: Study

December 17, 2011

FRIDAY, Dec. 16 (HealthDay News) — The number of women with
breast cancer who receive targeted radiation to the breast after a
lumpectomy has jumped dramatically over the last decade.

However, only about a third of these women were considered “suitable”
for the treatment, according to criteria used in a new study published in
the Dec. 16 online issue of the Journal of the National Cancer

But guidelines on which women should or should not receive this type of
radiation treatment, known as brachytherapy, are only newly published and
it’s unclear what the findings might mean to current breast cancer

Use of “accelerated partial breast irradiation using brachytherapy” has
risen steadily since about 2002, said study author Dr. Jona Hattangadi, a
radiation oncologist with Brigham and Women’s Hospital and the Harvard
Radiation Oncology Program in Boston.

Although brachytherapy is vastly more convenient (taking place over the
course of a week rather than six weeks), the worry is that directed
radiation isn’t comprehensive enough to find and kill all cancer cells
lingering in the breast as compared with the current standard, whole
breast radiation (WBI).

So, in 2009, the American Society for Radiation Oncology (ASTRO) issued
the first guidelines for the use of brachytherapy, which identified
patients as either “suitable,” “cautionary” (suitability unclear) or
“unsuitable” for the treatment, depending on a number of factors including
age as well as various tumor characteristics.

These authors rounded up data on 138,815 U.S. women who had been
diagnosed with breast cancer from 2000 to 2007 and who had either
undergone brachytherapy or whole breast irradiation after a lumpectomy.

Some 2.6 percent of women underwent brachytherapy, two thirds of whom
were either deemed “cautionary” (29.6 percent) or “unsuitable” (36.2
percent) according to ASTRO criteria.

Only about a third (32 percent) of patients would have been considered
suitable under ASTRO’s recommendations, the study authors said.

Use of brachytherapy rose from less than 1 percent in 2000 to almost 7
percent in 2007, but this varied greatly between geographical regions, the
researchers noted.

For instance, women in urban areas were more likely to get
brachytherapy than women in rural areas, which is surprising given that
rural women would have the most to benefit from the convenience.

And white women were more likely to get brachytherapy than black women
if they were considered “cautionary” or “unsuitable.”

It’s unclear what accounts for the variation or for the rise in
numbers, although the authors did postulate that reimbursement patterns
may play a role. Medicare started reimbursing for brachytherapy in

The main drawback of this study, the authors acknowledged, is that the
data was gathered before the ASTRO guidelines were published.

Dr. Eric Horwitz, M.D., chair of radiation oncology at Fox Chase Cancer
Center in Philadelphia, agreed that brachytherapy is “not for everybody”
but that “it’s an excellent technique if used on the right patients.”

But who is the right patient? Generally people with smaller, localized
tumors, he said.

Still, in the absence of long-term data, Hattangadi recommends that
women getting treatment for early-stage breast cancer have a “thorough
discussion with their physicians on the pros and cons of the approach.”

The findings come just a week after presenters at a national conference
found that women who had brachytherapy had double the rate of mastectomy
later on compared with women who got whole breast irradiation. That study
was led by Dr. Benjamin Smith of M.D. Anderson Cancer Center in Houston
and presented at the San Antonio Breast Cancer Symposium

More information

The U.S.
National Cancer Institute
has more on radiation therapy for cancer.

Article source: http://news.yahoo.com/targeted-radiation-breast-cancer-may-overused-study-210405856.html


Related posts:

  1. Drinking Risky for Women With Family History of Breast Cancer: Study
  2. Pro-life advocates: Study shows link between breast cancer and abortion; cancer institute: no way
  3. Breast cancer advances miss elderly patients
  4. Breast Cancer Gene Puts Survivors at Higher Odds for Recurrence
  5. 6 Things Women Can Do to Lower Breast Cancer Risk
  6. Diabetes, Obesity After 60 May Drive Up Breast Cancer Risk
  7. No extra birth defect risk after cancer treatment: study
  8. Side Effects May Spur Men to Drop Tamoxifen for Breast Cancer
  9. Targeted Drugs, Lung CT Screening Top Cancer Advances in 2011
  10. FDA revokes Avastin as breast cancer threatment


New post


March 2019
« Aug    


Recent comments

    Contact Sign In

    Email Marketing You Can Trust